Evidence map›Paper›PMID 39435173›Full record

ReviewJournal of neuroendovascular therapy2024

Efforts toward Gender Equality and Diversity in the Japanese Society for Neuroendovascular Therapy.

Yukiko Enomoto, Kenji Sugiu, Chiaki Sakai, Makoto Sakamoto, Yukako Yazawa, Mika Okahara, Ayuho Higaki, Tomoyoshi Shigematsu, Yuji Matsumaru

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of neuroendovascular therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yukiko EnomotoDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Gifu, Japan.
Kenji SugiuDepartment of Neurological Surgery, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan.
Chiaki SakaiCenter for Clinical Research and Innovation, Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Makoto SakamotoDivision of Neurosurgery, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Yukako YazawaDepartment of Stroke Neurology, Kohnan Hospital, Sendai, Miyagi, Japan.
Mika OkaharaDepartment of Radiology, Shinbeppu Hospital, Beppu, Oita, Japan.
Ayuho HigakiCenter of Endovascular Therapy, Division of Neuroendovascular Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Tomoyoshi ShigematsuDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Yuji MatsumaruStroke Prevention and Treatment, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japanese Society for Neuroendovascular Therapy (JSNET) is a diverse subspecialty society based on four basic fields and is continuously growing with the advancement of neuroendovascular therapy. Despite a recent increase in the proportion of female members, awareness of diversity within JSNET remains inadequate. To foster a more mature and inclusive society, we established the JSNET-Diversity Promotion Committee in 2021, which has actively engaged in various initiatives aimed at promoting the inclusion of minorities such as female physicians as well as minority fields. Our objective is to continue in our initiative, anticipating that JSNET will evolve into an even more ideal organization in the future.

Indexed as

diversity promotionfemale physiciansneuroendovascular therapy

Identifiers

PMID39435173
PMCPMC11491267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.